Matridx Biotechnology

Hangzhou Jieyi Biotechnology Co., Ltd., headquartered in Hangzhou, Zhejiang, is a high-tech enterprise focusing on genetic testing and using molecular technology as a platform. It is committed to providing customers with comprehensive molecular diagnostic solutions for infectious diseases. As an emerging molecular diagnostics company that integrates research and development, production, and sales, the company has independently developed a series of automated testing instruments and reagents based on two cutting-edge technological routes: gene editing (CRISPR/Cas) and next-generation sequencing (NGS). Jieyi Biotechnology has established close cooperation with many large medical institutions, disease control systems, and scientific research institutes across China, creating artificial intelligence diagnostic systems and services based on big data to promote the development of advanced medical testing. Adhering to the concept of "Innovating the Future of Diagnostics," Jieyi Biotechnology will lead molecular diagnostics into a new era.